First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.
暂无分享，去创建一个
E. Eisenhauer | I. Vergote | G. Kristensen | K. Lindemann | M. Izquierdo | G. Stuart | H. Hirte | E. Vrdoljak | J. Green | J. Kærn | H. Havsteen | M. Ridderheim | R. Christensen | A. López | E. Aavall-Lundquvist | H. Hirte | I. Vergote | E. A. Eisenhauer | Gunnar B. Kristensen | R. D. Christensen | John Green | G. Stuart | K. Lindemann